Search Results for "HIV"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for HIV. Results 71 to 80 of 181 total matches.

Pentamidine Aerosol To Prevent Pneumocystis Carinii Pneumonia

   
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989  (Issue 802)
initial episodes of PCP in HIV-positive patients occur when the blood CD4+ lymphocyte count is less than ...
Pneumocystis carinii pneumonia (PCP) occurs in nearly 80% of patients with the acquired immune deficiency syndrome (AIDS) and is a common cause of morbidity and mortality. Oral trimethoprim-sulfamethoxazole (Bactrim; and others), intravenous isethionate (Pentam 300) and other systemic drugs have been used to prevent PCP, but in AIDS patients, all of these agents can occasionally cause severe adverse effects (Medical Letter, 30:94, 1988). Recently, the US Food and Drug Administration approved marketing of aerosolized pentamidine isethionate (NebuPent - LyphoMed) for this indication. Another...
Med Lett Drugs Ther. 1989 Oct 6;31(802):91-2 |  Show IntroductionHide Introduction

Drug Interactions with St. John's Wort

   
The Medical Letter on Drugs and Therapeutics • Jun 26, 2000  (Issue 1081)
(AUC) of the HIV-1 protease inhibitor indinavir (Crixivan) (SC Piscitelli et al, Lancet, 355:547, 2000 ...
Even though its effectiveness has not been established, many patients take St. John's Wort (Hypericum perforatum), an over-the-counter herbal extract, to treat symptoms of depression, often without the knowledge of their physicians. Recent reports indicate that St. John's wort interacts adversely with a number of drugs.
Med Lett Drugs Ther. 2000 Jun 26;42(1081):56 |  Show IntroductionHide Introduction

Figure 2: Pneumococcal Vaccine Recommendations for Adults ≥65 Years Old (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 14, 2024  (Issue 1713)
immunosuppression, generalized malignancy, HIV infection, Hodgkin disease, leukemia, lymphoma, multiple myeloma ...
View Figure 2: Pneumococcal Vaccine Recommendations for Adults ≥65 Years Old
Med Lett Drugs Ther. 2024 Oct 14;66(1713):e164   doi:10.58347/tml.2024.1713g |  Show IntroductionHide Introduction

Entecavir (Baraclude) for Chronic Hepatitis B

   
The Medical Letter on Drugs and Therapeutics • Jun 06, 2005  (Issue 1210)
against HIV. ADVERSE EFFECTS — Lactic acidosis and severe hepatomegaly with steatosis have been reported ...
Entecavir (Baraclude - Bristol-Myers Squibb), a nucleoside analog, has been approved by the FDA for treatment of adults with active chronic hepatitis B virus (HBV) infection.
Med Lett Drugs Ther. 2005 Jun 6;47(1210):47-8 |  Show IntroductionHide Introduction

Posaconazole (Noxafil) for Invasive Fungal Infections

   
The Medical Letter on Drugs and Therapeutics • Nov 20, 2006  (Issue 1248)
, for treatment of oropharyngeal candidiasis in patients infected with HIV, clinical success rates were similar ...
Posaconazole (Noxafil - Schering-Plough), an oral azole antifungal with a chemical structure similar to that of itraconazole (Sporanox), has been approved by the FDA to prevent Candida and Aspergillus infections in severely immunocompromised patients and for treatment of oropharyngeal candidiasis. It is likely also to be used off-label for treatment of other fungal infections, including those caused by Mucor and other Zygomycetes.
Med Lett Drugs Ther. 2006 Nov 20;48(1248):93-5 |  Show IntroductionHide Introduction

Hemofil M - A New Antihemophilic Factor

   
The Medical Letter on Drugs and Therapeutics • Jun 03, 1988  (Issue 767)
Monoclate will be adequate to prevent transmission of hepatitis and HIV infection remains to be established ...
At the beginning of this year, The Medical Letter reviewed Monoclate (Armour), a new, highly purified antihemophilic factor (AHF) prepared by immunoaffinity chromatography (Medical Letter, 30:1, 1988). Monoclate is more highly purified than older Factor VIII concentrates, but whether the combination of monoclonal antibody purification and dry heat used in preparing Monoclate will be adequate to prevent transmission of hepatitis and HIV infection remains to be established. Twenty-eight patients previously untreated with Factor VIII concentrate who have received Monoclate for periods...
Med Lett Drugs Ther. 1988 Jun 3;30(767):60 |  Show IntroductionHide Introduction

Dermal Fillers

   
The Medical Letter on Drugs and Therapeutics • May 07, 2007  (Issue 1260)
acid, a biodegradable in HIV patients synthetic polymer Zyderm, Zyplast Bovine collagen Fine lines ...
Several injectable products are available for soft tissue augmentation of wrinkles and folds. These fillers are often used in conjunction with botulinum toxin type A (Botox) injections.
Med Lett Drugs Ther. 2007 May 7;49(1260):39-40 |  Show IntroductionHide Introduction

Intravenous Immunoglobulin (IVIG)

   
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006  (Issue 1249)
corticosteroids 8 Kawasaki disease Has been shown to prevent coronary artery aneurysms 9 Pediatric HIV* Could ...
Intravenous immunoglobulin (IVIG) has 6 FDA approved indications and is prescribed off-label for many others. How many of these uses are justified is controversial.
Med Lett Drugs Ther. 2006 Dec 4;48(1249):101-2 |  Show IntroductionHide Introduction

In Brief: A Potentially Fatal Immune Reaction to Lamotrigine

   
The Medical Letter on Drugs and Therapeutics • Jun 18, 2018  (Issue 1549)
. Often induced by Epstein-Barr Virus infection (HIV infection and non-Hodgkin’s lymphoma ...
The FDA has warned that the antiepileptic and mood-stabilizing drug lamotrigine (Lamictal, and generics) can rarely cause hemophagocytic lymphohistiocytosis (HLH), a serious and potentially fatal immune-related reaction.1HLH, which can be familial, occurs most often in infants, but can occur at any age. Often induced by Epstein-Barr Virus infection (HIV infection and non-Hodgkin's lymphoma are other common triggers), HLH is characterized by an unremitting activation of CD8+ T cells and macrophages.2 If untreated, it causes organ damage, particularly in the liver, bone marrow, and CNS; organ...
Med Lett Drugs Ther. 2018 Jun 18;60(1549):105 |  Show IntroductionHide Introduction

Foscarnet

   
The Medical Letter on Drugs and Therapeutics • Jan 10, 1992  (Issue 861)
transcriptase of human immunodeficiency virus (HIV) at a different site from nucleoside analogs ...
Phosphonoformic acid or foscarnet (Foscavir - Astra), a synthetic antiviral drug, has now been approved by the US Food and Drug Administration for intravenous (IV) treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. CMV retinitis occurs in up to 30% of patients with AIDS and often causes blindness (MD de Smet and RB Nussenbatt, JAMA, 266:3019, Dec 4, 1991).
Med Lett Drugs Ther. 1992 Jan 10;34(861):3-4 |  Show IntroductionHide Introduction